search
Back to results

Text Messaging for Weight Loss

Primary Purpose

Body Weight, Body Weight Changes, Prediabetic State

Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Text Message Based Weight Loss Support
Sponsored by
Denver Health and Hospital Authority
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional health services research trial for Body Weight focused on measuring weight loss, Text Messaging, Short Message Service, Text Messages

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • ≥ 18 years of age or older
  • Ownership of a cell phone with SMS capabilities
  • HbA1c greater than 5.6 but less than 6.5
  • BMI ≥ 25 kg/m2 and less than 50 kg/m2
  • English or Spanish speakers.

Exclusion Criteria:

  • Individuals with co-morbid illness with life expectancy less than 12 months (e.g., terminal cancer, Child's Class C hepatic cirrhosis)
  • Diabetes based on an ICD-9 code in previous 3 years
  • Institutionalized individuals
  • Individuals not planning to stay in the area at least 6 months.

Sites / Locations

  • Denver Health

Arms of the Study

Arm 1

Arm 2

Arm Type

No Intervention

Experimental

Arm Label

Usual Care for Weight Loss

Text Message Based Weight Loss Support

Arm Description

Patients randomized to this arm will not receive text messages or any other weight-loss support besides usual care provided at Denver Health. They will receive a weight loss educational packet and be asked to follow up with their primary care provider to further discuss their efforts at weight loss with additional follow-up as directed by their provider. They will be contacted periodically to be weighed. Providers will not be made aware that their patients are participating in the study's control arm.

Patients will receive the same weight loss educational packet as those randomized to usual care. Patients will be assisted in choosing a self-management goal related to exercise and to eating behaviors. They will receive text messages at a frequency up to 1x daily; input from focus groups will guide text message frequency.

Outcomes

Primary Outcome Measures

Absolute weight loss in pounds
Outcomes will be analyzed at baseline and at 6-month and 12-month follow-ups.

Secondary Outcome Measures

Percent weight loss
Outcomes will be analyzed at baseline and at 6-month and 12-month follow-ups.
Change in glycemic control as measured by HbA1c and fasting glucose
Patient Engagement Measures
Response rate to text message prompts
Percent of patients who maintain or lose weight
defined as weight gain less than two pounds
Changes in systolic and diastolic blood pressure
based on usual care measurements
Change in LDL-cholesterol
based on usual care measurements
Operating costs per participant receiving intervention
Costs from the perspective of the health system, including all personnel costs and technology costs, will be calculated. The upper 2.5% of the cost distribution curve will be truncated to eliminate outliers that would artificially skew results and use non-parametric methods if the distribution is non-normal as expected. The effect of scaling the intervention up two-fold and five-fold will undergo sensitivity analyses.
Patient Engagement Measures
Acceptability of the text-message based approach through individual interviews

Full Information

First Posted
February 10, 2014
Last Updated
January 19, 2016
Sponsor
Denver Health and Hospital Authority
Collaborators
Center for Health Systems Research at Denver Health, Colorado Health Outcomes Program
search

1. Study Identification

Unique Protocol Identification Number
NCT02063048
Brief Title
Text Messaging for Weight Loss
Official Title
The Comparative Effectiveness of Clinic-Based Weight Loss Strategies
Study Type
Interventional

2. Study Status

Record Verification Date
January 2016
Overall Recruitment Status
Completed
Study Start Date
April 2014 (undefined)
Primary Completion Date
May 2015 (Actual)
Study Completion Date
May 2015 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Denver Health and Hospital Authority
Collaborators
Center for Health Systems Research at Denver Health, Colorado Health Outcomes Program

4. Oversight

Data Monitoring Committee
Yes

5. Study Description

Brief Summary
The purpose of this study is to compare the effectiveness of text message-based support to usual care at promoting weight loss in patients with pre-diabetes.
Detailed Description
Text messaging has been shown to be effective for weight-loss in very limited testing. DH has experience with both text message based intervention and weight management intervention. This study aims to enhance Denver Health's (DH) existing Patient Relationship Management (PRM) text message (SMS) infrastructure to include culturally-appropriate outreach to promote weight loss. Subjects will be randomized into one of two arms: Usual care: Patients randomized to this arm will not receive text messages or any other weight-loss support besides usual care provided at DH. They will receive a weight loss educational packet and be asked to follow up with their primary care provider to further discuss their efforts at weight loss with additional follow-up as directed by their provider. They will be contacted periodically to be weighed. Providers will not be made aware that their patients are participating in the study's control arm. Text Message-based weight loss support. Patients will receive the same weight loss educational packet as those randomized to usual care. Patients will be assisted in choosing a self-management goal related to exercise and to eating behaviors. They will receive text messages at a frequency up to 1x daily; input from focus groups will guide text message frequency. SMS content is similar to the Diabetes Prevention Program (DPP) curriculum and will fall into the following categories: Outgoing "tips of the day" Interactive messages that solicit a simple response for the day from the participant Outgoing reminders to inform participant about events in the community and about clinic appointments with their primary care provider. Basic descriptive statistics for categorical variables will be generated to describe the baseline demographic and clinical characteristics. Univariate analyses will be performed to determine whether there are differences between patients in the three arms of the intervention. For clinical outcomes, general linear mixed effects models will be used with intervention and time (and their interactions) specified as fixed effects to determine whether change over time in outcomes differs significantly for the three groups. A random subject effect will be specified to model the correlation of observations taken on an individual. Contrasts will be constructed to test the difference in interventions at six months and 12 months. If the data do not follow an approximate normal distribution or cannot be normalized using log transformation the ranks of the outcomes will be analyzed in the mixed effects model. All statistical analyses will be performed using Statistical Analysis Software (SAS) version 9.2. The study is powered to detect a difference at six months between the text message group and the usual care group. Previous research suggests that, with 60 participants per group, researchers would have 89% power to detect a difference between groups of 1.7 kg. The investigators think that this is a reasonable estimate, as subjects in the control group in this study lost 0.4 kg, and it is believed that subjects in the control group will be weight stable. While investigators anticipate that patients who participate in the DPP program will lose weight, it is believed participation across the usual care and SMS groups will be comparable as i) randomization is stratified to the two groups by past participation in the DPP and ii) relatively equal participation in the two groups is anticipated throughout the intervention period. This stratification is intended to equalize the effects of class-attendance heterogeneity across the two study groups. The study aims to have 90 participants per group to improve the power for sub-group analyses.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Body Weight, Body Weight Changes, Prediabetic State, Prediabetes
Keywords
weight loss, Text Messaging, Short Message Service, Text Messages

7. Study Design

Primary Purpose
Health Services Research
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
163 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Usual Care for Weight Loss
Arm Type
No Intervention
Arm Description
Patients randomized to this arm will not receive text messages or any other weight-loss support besides usual care provided at Denver Health. They will receive a weight loss educational packet and be asked to follow up with their primary care provider to further discuss their efforts at weight loss with additional follow-up as directed by their provider. They will be contacted periodically to be weighed. Providers will not be made aware that their patients are participating in the study's control arm.
Arm Title
Text Message Based Weight Loss Support
Arm Type
Experimental
Arm Description
Patients will receive the same weight loss educational packet as those randomized to usual care. Patients will be assisted in choosing a self-management goal related to exercise and to eating behaviors. They will receive text messages at a frequency up to 1x daily; input from focus groups will guide text message frequency.
Intervention Type
Behavioral
Intervention Name(s)
Text Message Based Weight Loss Support
Primary Outcome Measure Information:
Title
Absolute weight loss in pounds
Description
Outcomes will be analyzed at baseline and at 6-month and 12-month follow-ups.
Time Frame
12 months
Secondary Outcome Measure Information:
Title
Percent weight loss
Description
Outcomes will be analyzed at baseline and at 6-month and 12-month follow-ups.
Time Frame
12 months
Title
Change in glycemic control as measured by HbA1c and fasting glucose
Time Frame
12 months
Title
Patient Engagement Measures
Description
Response rate to text message prompts
Time Frame
12 months
Title
Percent of patients who maintain or lose weight
Description
defined as weight gain less than two pounds
Time Frame
12 months
Title
Changes in systolic and diastolic blood pressure
Description
based on usual care measurements
Time Frame
12 months
Title
Change in LDL-cholesterol
Description
based on usual care measurements
Time Frame
12 months
Title
Operating costs per participant receiving intervention
Description
Costs from the perspective of the health system, including all personnel costs and technology costs, will be calculated. The upper 2.5% of the cost distribution curve will be truncated to eliminate outliers that would artificially skew results and use non-parametric methods if the distribution is non-normal as expected. The effect of scaling the intervention up two-fold and five-fold will undergo sensitivity analyses.
Time Frame
12 months
Title
Patient Engagement Measures
Description
Acceptability of the text-message based approach through individual interviews
Time Frame
12 months

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: ≥ 18 years of age or older Ownership of a cell phone with SMS capabilities HbA1c greater than 5.6 but less than 6.5 BMI ≥ 25 kg/m2 and less than 50 kg/m2 English or Spanish speakers. Exclusion Criteria: Individuals with co-morbid illness with life expectancy less than 12 months (e.g., terminal cancer, Child's Class C hepatic cirrhosis) Diabetes based on an ICD-9 code in previous 3 years Institutionalized individuals Individuals not planning to stay in the area at least 6 months.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Henry Fischer, MD
Organizational Affiliation
Denver Health
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Edward Havranek, MD
Organizational Affiliation
Denver Health
Official's Role
Study Director
Facility Information:
Facility Name
Denver Health
City
Denver
State/Province
Colorado
ZIP/Postal Code
80204
Country
United States

12. IPD Sharing Statement

Citations:
PubMed Identifier
27926904
Citation
Fischer HH, Pereira RI, Moore SL, Durfee MJ, Rozwadowski JM, Havranek EP. Response to Comment on Fischer et al. Text Message Support for Weight Loss in Patients With Prediabetes: A Randomized Clinical Trial. Diabetes Care 2016;39:1364-1370. Diabetes Care. 2016 Nov;39(11):e207-e208. doi: 10.2337/dci16-0024. No abstract available.
Results Reference
derived
PubMed Identifier
26861922
Citation
Fischer HH, Fischer IP, Pereira RI, Furniss AL, Rozwadowski JM, Moore SL, Durfee MJ, Raghunath SG, Tsai AG, Havranek EP. Text Message Support for Weight Loss in Patients With Prediabetes: A Randomized Clinical Trial. Diabetes Care. 2016 Aug;39(8):1364-70. doi: 10.2337/dc15-2137. Epub 2016 Feb 9.
Results Reference
derived

Learn more about this trial

Text Messaging for Weight Loss

We'll reach out to this number within 24 hrs